Skip to main content
. 2022 Mar 17;9:817826. doi: 10.3389/fcvm.2022.817826

FIGURE 4.

FIGURE 4

Diagnostic accuracy of a universal, heparin-calibrated anti-Xa assay for the measurement of rivaroxaban, apixaban, and edoxaban drug concentrations in clinical practice (derivation dataset; n = 422). (A) Receiver-operating characteristics curve (ROC) showing the diagnostic accuracy. The area under the ROC curve was 0.99 for all cut-offs. (B) Confusion matrices at each cut-off. Drug levels above 30 μg L–1 were detected with a sensitivity of 96.9% (95% CI 94.3, 98.5; cut-off value 0.26 U mL–1), drug levels above 50 μg L–1 with a sensitivity of 95.2% (95% CI 92.0, 97.4; cut-off value 0.40), and drug levels above 100 μg L–1 with a sensitivity of 96.2% (95% CI 92.4, 98.5; cut-off value 0.77). Specificities were 92.2% (85.1, 96.6), 90.6% (84.7, 94.8), 88.1% (83.3, 92.0), respectively.